Rhythm Pharmaceuticals, Inc. / Estimates

    Fiscal Year Revenue Net income Net margin Free cash flow FCF margin
    (estimated) €1.19B +47.9% €549.47M +84.7% 46.1% +0.092 pp N/A N/A
    (estimated) €806.58M +71.8% €297.56M +547.4% 36.9% +0.27 pp N/A N/A
    (estimated) €469.51M +80.7% €45.97M -141.0% 9.8% +0.53 pp N/A N/A
    (estimated) €259.76M +63.4% -€112.16M -31.1% -43.2% +0.59 pp N/A N/A
    (estimated) €159.02M +43.3% -€162.73M -26.8% -102.3% +0.98 pp N/A N/A
    €110.99M +68.1% -€222.28M +41.1% -200.3% +0.38 pp -€97.13M -16.3% -87.5% +0.88 pp
    €66.04M +227.6% -€157.52M +0.9% -238.5% +5.4 pp -€116.10M -19.5% -175.8% +5.4 pp
    €20.16M +649.5% -€156.16M +169.2% -774.5% +14 pp -€144.27M +20.3% -715.6% +37 pp
    €2.69M +∞% -€58.01M -48.0% -2,156.2% -22 pp -€119.90M +15.4% -4,456.8% -45 pp
    €0.00 +NaN% -€111.50M -2.9% N/A -€103.86M +2.0% N/A
    €0.00 +NaN% -€114.83M +81.8% N/A -€101.81M +94.6% N/A
    €0.00 +NaN% -€63.17M +119.7% N/A -€52.31M +109.1% N/A
    €0.00 +NaN% -€28.75M +30.3% N/A -€25.01M +32.3% N/A
    €0.00 +NaN% -€22.07M +133.6% N/A -€18.90M +218.4% N/A
    €0.00 +NaN% -€9.44M +70.5% N/A -€5.94M -7.3% N/A
    €0.00 +NaN% -€5.54M -69.7% N/A -€6.40M -60.8% N/A
    €0.00 +NaN% -€18.28M +18.2% N/A -€16.34M +7.4% N/A
    €0.00 -€15.46M N/A -€15.21M N/A

    Notifications